Mice were vaccinated with syngeneic bone marrow-derived DCs loaded with either pancreatic cancer (in KPC mice) or mesothelioma (in AE17 mice) lysate and consequently treated with FGK45 as a CD40 agonist. Here, CD40 is linked to mesothelioma.